The first gene-silencing drug wins FDA approval
Using RNA interference, patisiran prevents symptoms by blocking DNA instructions
INTERCEPTION Small bits of RNA can latch onto longer messenger RNA molecules that are carrying DNA’s instructions to make proteins (illustrated), halting the production process. A newly approved drug uses this natural process to turn off a specific gene.
BSIP SA/Alamy
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
